319927-23-6

319927-23-6 structure

Name: (Des-Asp187)-Melanocyte Protein PMEL 17 (185-193) (human, bovine, mouse)
Chemical Name: N-[(2S)-2-{[(2S)-2-({[(2S)-1-{N-[(2S)-2-{[(2S,3R)-2-{[(2S,3S)-2-Amino-1-hydroxy-3-methylpentylidene]amino}-1,3-dihydroxybutylidene]amino}-1,5-dihydroxy-5-iminopentylidene]-L-valyl}-2-pyrrolidinyl](hydroxy)methylene}amino)-1-hydroxy-3-phenylpropylidene]amino}-1,3-dihydroxypropylidene]-L-valine
CAS Number: 319927-23-6
Molecular Formula: C₄₂H₆₇N₉O₁₂
Molecular Weight: 890.03400
Catalog: Research Areas Cancer
Create Date: 2016-03-12 15:22:13
Modify Date: 2025-09-13 09:49:07
Gp100:209-217 is a gp 100-derived human CTL epitope presented by HLA-A2. Gp100:209-217 is a polypeptide containing eight amino acids. Gp100:209-217 is a potent TGF-β inhibitor and blocks TGF-β signaling pathway[1].

Name	N-[(2S)-2-{[(2S)-2-({[(2S)-1-{N-[(2S)-2-{[(2S,3R)-2-{[(2S,3S)-2-Amino-1-hydroxy-3-methylpentylidene]amino}-1,3-dihydroxybutylidene]amino}-1,5-dihydroxy-5-iminopentylidene]-L-valyl}-2-pyrrolidinyl](hydroxy)methylene}amino)-1-hydroxy-3-phenylpropylidene]amino}-1,3-dihydroxypropylidene]-L-valine
Synonyms	N-[(2S)-2-{[(2S)-2-({[(2S)-1-{N-[(2S)-2-{[(2S,3R)-2-{[(2S,3S)-2-Amino-1-hydroxy-3-methylpentylidene]amino}-1,3-dihydroxybutylidene]amino}-1,5-dihydroxy-5-iminopentylidene]-L-valyl}-2-pyrrolidinyl](hydroxy)methylene}amino)-1-hydroxy-3-phenylpropylidene]amino}-1,3-dihydroxypropylidene]-L-valine L-Valine, N-[(2S)-2-[[(2S)-2-[[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S,3S)-2-amino-1-hydroxy-3-methylpentylidene]amino]-1,3-dihydroxybutylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-3-methyl-1-oxobutyl]-2-pyrrolidinyl]hydroxymethylene]amino]-1-hydroxy-3-phenylpropylidene]amino]-1,3-dihydroxypropylidene]- (Des-Asp187)-Melanocyte Protein PMEL 17 (185-193) (human, bovine, mouse)

Description	Gp100:209-217 is a gp 100-derived human CTL epitope presented by HLA-A2. Gp100:209-217 is a polypeptide containing eight amino acids. Gp100:209-217 is a potent TGF-β inhibitor and blocks TGF-β signaling pathway[1].
Related Catalog	Research Areas >> Cancer
References	[1]. Terabe M, et, al. Synergistic effect of TGF-β blockade and immunogenic agents on tumors. WO2006089251.